2025-03-24 02:04:55
Latest Post
NCC Limited receives contract worth Rs. 1480.34 crore
IIFL Capital Services Ltd announces changes in top management
EPACK Durable Ltd receives approval for disbursement of 2nd tranche of incentive under PLI Scheme for White Goods
Ola Electric Commences Deliveries of S1 Gen 3 Scooters Across India
Raymond Ltd to invest an amount up to Rs. 65 crore in Ten X Realty East Ltd
Stock Report
Thyrocare Technologies Ltd posts higher consolidated net profit of Rs. 26.67 crores in Q2 FY2024-25
Posted On : 2024-10-24 00:29:24( TIMEZONE : IST )
Thyrocare Technologies Limited has reported Consolidated financial results for the period ended September 30, 2024.
Financial Results (Q2 FY2025) - QoQ Comparison
The company has reported total income of Rs. 179.97 crores during the period ended September 30, 2024 as compared to Rs. 160.53 crores during the period ended June 30, 2024.
The company has posted net profit / (loss) of Rs. 26.67 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs. 24.17 crores for the period ended June 30, 2024.
The company has reported EPS of Rs. 4.98 for the period ended September 30, 2024 as compared to Rs. 4.51 for the period ended June 30, 2024.
| Financials | Q2 FY2025 | Q1 FY2025 | % Change |
| Total Income | ₹ 179.97 crs | ₹160.53 crs |  12.11% |
| Net Profit | ₹26.67 crs | ₹24.17 crs | 10.34% |
| EPS | ₹4.98 | ₹4.51 | 10.42% |
Financial Results (Q2 FY2025) - YoY Comparison
The company has reported total income of Rs. 179.97 crores during the period ended September 30, 2024 as compared to Rs.150.17 crores during the period ended September 30, 2023.
The company has posted net profit / (loss) of Rs.26.67 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs.20.34 crores for the period ended September 30, 2023.
The company has reported EPS of Rs.4.98 for the period ended September 30, 2024 as compared to Rs.3.84 for the period ended September 30, 2023.
| Financials | Q2 FY2025 | Q2 FY2024 | % Change |
| Total Income | ₹ 179.97 crs | ₹150.17 crs | 19.84% |
| Net Profit | ₹26.67 crs | ₹20.34 crs | 31.12% |
| EPS | ₹4.98 | ₹3.84 | 29.69% |
Financial Results (Half Year Ended FY2025) - YoY Comparison
The company has reported total income of Rs.340.50 crores during the 6 Months period ended September 30, 2024 as compared to Rs.286.04 crores during the 6 Months period ended September 30, 2023.
The company has posted net profit / (loss) of Rs.50.84 crores for the 6 Months period ended September 30, 2024 as against net profit / (loss) of Rs.37.64 crores for the 6 Months period ended September 30, 2023.
The company has reported EPS of Rs.9.49 for the 6 Months period ended September 30, 2024 as compared to Rs.7.09 for the 6 Months period ended September 30, 2023.
| Financials | Half Year Ended FY2025 | Half Year Ended FY2024 | % Change |
| Total Income | ₹340.50 crs | ₹286.04 crs | 19.04% |
| Net Profit | ₹50.84 crs | ₹37.64 crs | 35.07% |
| EPS | ₹9.49 | ₹7.09 | 33.85% |
Shares of Thyrocare Technologies Limited was last trading in BSE at Rs. 908.35 as compared to the previous close of Rs. 886.45. The total number of shares traded during the day was 11157 in over 1903 trades.
The stock hit an intraday high of Rs. 930.00 and intraday low of 862.10. The net turnover during the day was Rs. 10025304.00.
